Alhazmi AY - Search Results

1

Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid's Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations.

Hakami MA, Hazazi A, Albloui F, Gharib AF, Alsaeedi FA, Abdulaziz O, Alhazmi AY, Alsaiari AA. Hakami MA, et al. Among authors: alhazmi ay. Int J Mol Sci. 2024 Jan 2;25(1):592. doi: 10.3390/ijms25010592. Int J Mol Sci. 2024. PMID: 38203761 Free PMC article.

2

Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study.

Almasoudi HH, Hakami MA, Alhazmi AY, Makkawi M, Alasmari S, Alghamdi YS, Mashraqi MM. Almasoudi HH, et al. Among authors: alhazmi ay. Med Oncol. 2023 Jul 2;40(8):218. doi: 10.1007/s12032-023-02094-7. Med Oncol. 2023. PMID: 37394519

3

HOTAIR: A key regulator of the Wnt/β-catenin signaling cascade in cancer progression and treatment.

Hakami MA, Hazazi A, Abdulaziz O, Almasoudi HH, Alhazmi AYM, Alkhalil SS, Alharthi NS, Alhuthali HM, Almalki WH, Gupta G, Khan FR. Hakami MA, et al. Pathol Res Pract. 2024 Jan;253:154957. doi: 10.1016/j.prp.2023.154957. Epub 2023 Nov 19. Pathol Res Pract. 2024. PMID: 38000201 Review.

4

Delineating Pixantrone Maleate's adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation.

Almasoudi HH, Nahari MH, Alhazmi AYM, Almasabi SHA, Al-Mansour FSH, Hakami MA. Almasoudi HH, et al. Among authors: alhazmi aym. PLoS One. 2023 Dec 15;18(12):e0295714. doi: 10.1371/journal.pone.0295714. eCollection 2023. PLoS One. 2023. PMID: 38100507 Free PMC article.

5

Computational insights into overcoming resistance mechanisms in targeted therapies for advanced breast cancer: focus on EGFR and HER2 co-inhibition.

Abdulaziz O, Khan FR, Alharthi NS, Alhuthali HM, Hazazi A, Alzahrani HA, Gharib AF, Alsalmi OA, Hawsawi NM, Alhazmi AY. Abdulaziz O, et al. Among authors: alhazmi ay. J Biomol Struct Dyn. 2024 Jan 17:1-12. doi: 10.1080/07391102.2024.2301766. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38234016

6

Identification of potential therapeutic targets for COVID-19 through a structural-based similarity approach between SARS-CoV-2 and its human host proteins.

Tasneem A, Sultan A, Singh P, Bairagya HR, Almasoudi HH, Alhazmi AYM, Binshaya AS, Hakami MA, Alotaibi BS, Abdulaziz Eisa A, Alolaiqy ASI, Hasan MR, Dev K, Dohare R. Tasneem A, et al. Among authors: alhazmi aym. Front Genet. 2024 Feb 2;15:1292280. doi: 10.3389/fgene.2024.1292280. eCollection 2024. Front Genet. 2024. PMID: 38370514 Free PMC article.

7

Structural and energetic analysis of NS5 protein inhibition by small molecules in Japanese encephalitis virus using machine learning and steered molecular dynamics approach.

Alhazmi AY, Khan FR, Rehman ZU, Hazazi A, Alotaibi BS, Alharthi NS, Alhuthali HM, Aba Alkhayl FF, Alshehri FF, Alkhoshaiban A, Al-Otaibi F. Alhazmi AY, et al. J Biomol Struct Dyn. 2024 Feb 26:1-18. doi: 10.1080/07391102.2024.2316767. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38407246

8

Sakuranetin ameliorates streptozotocin-induced diabetes in rodents by inhibiting caspase-3 activity, modulating hematological parameters, and suppressing inflammatory cytokines: a molecular docking and dynamics study.

Almasoudi HH, Nahari MH, Binshaya AS, Hakami MA, Alhazmi AY, Al Shmrany H, Alqasem A, Khan FR. Almasoudi HH, et al. Among authors: alhazmi ay. J Biomol Struct Dyn. 2024 Mar 9:1-18. doi: 10.1080/07391102.2024.2325659. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38459941

9

Phenolic phytochemistry, in vitro, in silico, in vivo, and mechanistic anti-inflammatory and antioxidant evaluations of Habenaria digitata.

Almasoudi HH, Saeed Jan M, Nahari MH, Alhazmi AYM, Binshaya AS, Abdulaziz O, Mahnashi MH, Ibrar M, Zafar R, Sadiq A. Almasoudi HH, et al. Among authors: alhazmi aym. Front Pharmacol. 2024 Feb 29;15:1346526. doi: 10.3389/fphar.2024.1346526. eCollection 2024. Front Pharmacol. 2024. PMID: 38487169 Free PMC article.

10

Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor.

Almasoudi HH, Mashraqi MM, Alshamrani SA, Alharthi AA, Alsalmi O, Nahari MH, Al-Mansour FSH, Alhazmi AYM. Almasoudi HH, et al. Among authors: alhazmi aym. Pharmaceuticals (Basel). 2024 Feb 6;17(2):208. doi: 10.3390/ph17020208. Pharmaceuticals (Basel). 2024. PMID: 38399423 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page